Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits

American Journal of Transplantation

Volumn 9, Issue 6, 2009, Pages 1362-1372

  Li, L ^a   Chang, A ^a   Naesens, M ^a   Kambham, N ^a   Waskerwitz, J ^a   Martin, J ^a   Wong, C ^a   Alexander, S ^a   Grimm, P ^a   Concepcion, W ^a   Salvatierra, O ^a   Sarwal, M M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Kidney transplantation; Pediatrics; Steroid free

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR RISK; CHILD; CREATININE CLEARANCE; DIABETES MELLITUS; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT SELECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SCHOOL CHILD; STEROID THERAPY;

ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE;

EID: 66249123239     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02640.x     Document Type: Article

References (51)

1. Delucchi A, Valenzuela M, Ferrario M et al. Early steroid withdrawal in pediatric renal transplant on newer immunosuppressive drugs. Pediatr Transplant 2007 11 : 743 748. (Pubitemid 47512316)
2. Shaw RJ, Palmer L, Blasey C, Sarwal M. A typology of non-adherence in pediatric renal transplant recipients. Pediatr Transplant 2003 7 : 489 493. (Pubitemid 37466212)
3. Vidhun JR, Sarwal MM. Corticosteroid avoidance in pediatric renal transplantation. Pediatr Nephrol 2005 20 : 418 426. (Pubitemid 40309954)
4. Sarwal MM, Yorgin PD, Alexander S et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001 72 : 13 21. (Pubitemid 32652500)
5. Tonshoff B, Hocker B, Weber LT. Steroid withdrawal in pediatric and adult renal transplant recipients. Pediatr Nephrol 2005 20 : 409 417. (Pubitemid 40309953)
6. Starzl TE, Marchioro TL, Terasaki PI et al. Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg 1965 162 : 749 787.
7. Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: A meta-analysis. J Am Soc Nephrol 1993 4 : 1300 1305.
8. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000 11 : 1910 1917.
9. Ahsan N, Hricik D, Matas A et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil-A prospective randomized study. Steroid Withdrawal Study Group. Transplantation 1999 68 : 1865 1874. (Pubitemid 30027339)
10. Pascual J, Quereda C, Zamora J, Hernandez D. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: A meta-analysis of randomized, controlled trials. Transplantation 2004 78 : 1548 1556. (Pubitemid 39552943)
11. Lo Cascio V, Bonucci E, Imbimbo B et al. Bone loss after glucocorticoid therapy. Calcif Tissue Int 1984 36 : 435 438. (Pubitemid 14003835)
12. Laan RF, van Riel PL, van de Putte LB, van Erning LJ, van't Hof MA, Lemmens JA. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study. Ann Intern Med 1993 119 : 963 968. (Pubitemid 23334651)
13. Ruegsegger P, Medici TC, Anliker M. Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography. Eur J Clin Pharmacol 1983 25 : 615 620. (Pubitemid 14211628)
14. Starzl TE. FK 506 versus cyclosporine. Transplant Proc 1993 25 (1 Pt 1 511 512. (Pubitemid 23082455)
15. The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U. S. Multicenter FK506 Liver Study Group. N Engl J Med 1994 331 : 1110 1115.
16. Khwaja K, Asolati M, Harmon JV et al. Rapid discontinuation of prednisone in higher-risk kidney transplant recipients. Transplantation 2004 78 : 1397 1399. (Pubitemid 39507982)
17. Garcia R, Pinheiro-Machado PG, Felipe CR et al. Conversion from azathioprine to mycophenolate mofetil followed by calcineurin inhibitor minimization or elimination in patients with chronic allograft dysfunction. Transplant Proc 2006 38 : 2872 2878.
18. Sollinger HW. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U. S. Renal Transplant Mycophenolate Mofetil Study Group. Transplantation 1995 60 : 225 232.
19. Li L, Chaudhuri A, Weintraub LA et al. Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation. Pediatr Transplant 2007 11 : 187 195. (Pubitemid 46174991)
20. Birkeland SA. Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. Transplantation 1998 66 : 1207 1210. (Pubitemid 28530326)
21. Birkeland SA. Steroid-free immunosuppression in renal transplantation: A long-term follow-up of 100 consecutive patients. Transplantation 2001 71 : 1089 1090.
22. Cole E, Landsberg D, Russell D et al. A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation 2001 72 : 845 850. (Pubitemid 32879856)
23. Khwaja K, Asolati M, Harmon J et al. Outcome at 3 years with a prednisone-free maintenance regimen: A single-center experience with 349 kidney transplant recipients. Am J Transplant 2004 4 : 980 987. (Pubitemid 38745597)
24. Sarwal MM, Vidhun JR, Alexander SR, Satterwhite T, Millan M, Salvatierra O Jr. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation 2003 76 : 1331 1339. (Pubitemid 37430720)
25. ter Meulen CG, van Riemsdijk I, Hene RJ et al. Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: A prospective, randomized, multicenter study. Am J Transplant 2004 4 : 803 810. (Pubitemid 38637581)
26. Kandaswamy R, Melancon JK, Dunn T et al. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients-an interim analysis. Am J Transplant 2005 5 : 1529 1536. (Pubitemid 40839448)
27. Matas AJ, Kandaswamy R, Gillingham KJ et al. Prednisone-free maintenance immunosuppression-a 5-year experience. Am J Transplant 2005 5 : 2473 2478. (Pubitemid 43919432)
28. Woodle ES, Alloway RR, Buell JF et al. Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression. Am J Transplant 2005 5 : 2740 2744. (Pubitemid 43920069)
29. Kumar MS, Heifets M, Moritz MJ et al. Safety and efficacy of steroid withdrawal two days after kidney transplantation: Analysis of results at three years. Transplantation 2006 81 : 832 839.
30. Rajab A, Pelletier RP, Henry ML, Ferguson RM. Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression. Clin Transplant 2006 20 : 537 546. (Pubitemid 44383398)
31. Naesens M, Salvatierra O, Li L, Kambham N, Concepcion W, Sarwal M. Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients. Transplantation 2008 85 : 1139 1145.
32. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999 55 : 713 723. (Pubitemid 29082898)
33. Schwartz GJ, Feld LG, Langford DJ. A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr 1984 104 : 849 854. (Pubitemid 14119952)
34. Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985 106 : 522 526. (Pubitemid 15140671)
35. Solez K, Colvin RB, Racusen LC et al. Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007 7 : 518 526. (Pubitemid 46376465)
36. NAPRTCS. NAPRTCS 2007 Annual Report. 2007.
37. Rostaing L, Cantarovich D, Mourad G et al. Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation. Transplantation 2005 79 : 807 814. (Pubitemid 40546200)
38. Almawi WY, Melemedjian OK, Rieder MJ. An alternate mechanism of glucocorticoid anti-proliferative effect: Promotion of a Th2 cytokine-secreting profile. Clin Transplant 1999 13 : 365 374. (Pubitemid 29462185)
39. Satterwhite T, Chua MS, Hsieh SC et al. Increased expression of cytotoxic effector molecules: Different interpretations for steroid-based and steroid-free immunosuppression. Pediatr Transplant 2003 7 : 53 58. (Pubitemid 36314191)
40. Baumann S, Dostert A, Novac N et al. Glucocorticoids inhibit activation-induced cell death (AICD) via direct DNA-dependent repression of the CD95 ligand gene by a glucocorticoid receptor dimer. Blood 2005 106 : 617 625. (Pubitemid 40981259)
41. Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am J Transplant 2008 8 : 307 316.
42. Woodle ES. A randomized double blind, placebo-controlled trial of early corticosteroid cessation versus chronic corticosteroids: Five year results. Am J Transplant 2008 8 (Suppl 2 300.
43. Sinclair NR. Four decades of glucocorticosteroid immunosuppression. CMAJ 1993 148 : 1277 1278. (Pubitemid 23144488)
44. Gallon L, Perico N, Dimitrov BD et al. Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF. Am J Transplant 2006 6 : 1617 1623. (Pubitemid 43945801)
45. Gallon LG, Winoto J, Chhabra D, Parker MA, Leventhal JR, Kaufman DB. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: Tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Transplantation 2007 83 : 1324 1329. (Pubitemid 46800307)
46. Stock PG, Ascher NL, Osorio RW et al. Standard sequential immunosuppression with Minnesota antilymphoblast globulin and cyclosporine vs FK 506: A comparison of early nephrotoxicity. Transplant Proc 1993 25 (1 Pt 1 675 676. (Pubitemid 23082513)
47. Chang GJ, Mahanty HD, Vincenti F et al. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function. Clin Transplant 2000 14 : 550 554.
48. Naesens M, Kambham N, Concepcion W, Salvatierra O Jr., Sarwal M. The evolution of nonimmune histological injury and its clinical relevance in adult-sized kidney grafts in pediatric recipients. Am J Transplant 2007 7 : 2504 2514. (Pubitemid 47561598)
49. Cattaneo D, Perico N, Gaspari F, Gotti E, Remuzzi G. Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation. Kidney Int 2002 62 : 1060 1067. (Pubitemid 35316738)
50. Anil Kumar MS, Moritz MJ, Saaed MI et al. Avoidance of chronic steroid therapy in African American kidney transplant recipients monitored by surveillance biopsy: 1-year results. Am J Transplant 2005 5 : 1976 1985. (Pubitemid 41039874)
51. Alloway RR, Hanaway MJ, Trofe J et al. A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: The Cincinnati experience. Transplant Proc 2005 37 : 802 803. (Pubitemid 40590706)